These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 6539221)

  • 41. [The effect of the type of diabetes,the HLA type and metabolic status on cellular immunity in diabetic patients].
    Zamaklar M; Devecerski M; Petrović M; Andjeloković S; Drezgić M
    Glas Srp Akad Nauka Med; 1985; (37):69-75. PubMed ID: 3842683
    [No Abstract]   [Full Text] [Related]  

  • 42. An investigation into cytotoxic mechanisms in type I diabetes mellitus.
    Richens ER; Quilley J; Hartog M
    Acta Diabetol Lat; 1982; 19(4):329-37. PubMed ID: 6983808
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Characteristics of the course of odontogenic suppurative-inflammatory processes of the maxillofacial area in patients with insulin-dependent and insulin-independent diabetes mellitus].
    Meser A
    Stomatologiia (Mosk); 1989; 68(4):41-4. PubMed ID: 2815128
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cell-mediated immunity and immune complexes in the pathogenesis of type 1 (insulin-dependent) diabetes.
    Pozzilli P; Di Mario U; Andreani D
    Acta Diabetol Lat; 1982; 19(4):295-300. PubMed ID: 6758457
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Antibody-dependent killer-cell function in insulin-dependent diabetes mellitus.
    Ludwig H; Schernthaner G; Kraft D; Scheiner O; Mayr WR
    J Endocrinol Invest; 1980; 3(1):39-44. PubMed ID: 6989889
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Immune reactions in patients with type I and with type II diabetes mellitus.
    Horváth M; Varsányi M; Jovanovich N; Rózsás Z; Balázsi I
    Exp Clin Endocrinol; 1987 Aug; 89(3):354-62. PubMed ID: 3499333
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Evidence that the reduced number of natural killer cells in type 1 (insulin-dependent) diabetes may be genetically determined.
    Hussain MJ; Alviggi L; Millward BA; Leslie RD; Pyke DA; Vergani D
    Diabetologia; 1987 Dec; 30(12):907-11. PubMed ID: 3436487
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Cellular immunity in patients with newly detected insulin-dependent diabetes mellitus].
    Dedov II; Chugunova LA; Smirnova OM; Brykova SV; Shchegol'kova TS
    Probl Endokrinol (Mosk); 1994; 40(1):17-20. PubMed ID: 8165207
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cellular and humoral immunity in patients with insulin-dependent diabetes.
    Bansal AS; Wilson PB; Pumphrey RS; Boulton AJ; Malik RA
    Lancet; 1993 Jul; 342(8865):246. PubMed ID: 8100969
    [No Abstract]   [Full Text] [Related]  

  • 50. Study on some opportunistic parasitic infections in Egyptian diabetic patients.
    Farrag SA; Morsy TA; Makarem SS; Sarwat MA
    J Egypt Soc Parasitol; 1988 Jun; 18(1):197-205. PubMed ID: 3373047
    [No Abstract]   [Full Text] [Related]  

  • 51. [Age-related features of immunocompetent cells of human placenta associated with diabetes mellitus].
    Durnova AO; Poliakova VO; Pal'chenko NA
    Adv Gerontol; 2010; 23(2):208-12. PubMed ID: 21033374
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The importance of measuring Fc+ (killer) cells in insulin-dependent (type 1) diabetes.
    Pozzilli P; Sensi M; Dean B; Gorsuch A; Cudworth A
    Acta Diabetol Lat; 1980; 17(2):119-22. PubMed ID: 7445912
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [The number and ultrastructure of large granule-containing lymphocytes (natural killer cells) in the blood of patients with diabetes mellitus type 1].
    Zak KP; Khomenko BM; Afanas'eva VV; Sakalo EA
    Probl Endokrinol (Mosk); 1987; 33(4):3-5. PubMed ID: 3658946
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [The function of the blood neutrophils in diabetics].
    Kazimirko VK
    Lik Sprava; 1995; (1-2):105-8. PubMed ID: 7483509
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Determination of alpha-2-macroglobulin concentration using immunologic and amidolytic methods in diabetics and kidney patients].
    Discher T; Velcovsky HG; Federlin K
    Immun Infekt; 1985 Feb; 13(1):21-3. PubMed ID: 2579893
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cellular cytotoxicity to membrane-associated insulin in an autologous system.
    Richens ER; Seward ME; Groves RW
    Acta Diabetol Lat; 1985; 22(1):55-62. PubMed ID: 3873773
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Natural killer cells in insulin dependent diabetes mellitus.
    Wilson RG; Anderson J; Shenton BK; White MD; Taylor RM; Proud G
    Br Med J (Clin Res Ed); 1986 Jul; 293(6541):244. PubMed ID: 3089475
    [No Abstract]   [Full Text] [Related]  

  • 58. Taming killer cells may halt diabetes progression.
    Colucci F; Cilio CM
    Nat Immunol; 2010 Feb; 11(2):111-2. PubMed ID: 20084067
    [No Abstract]   [Full Text] [Related]  

  • 59. Lack of immunity to bovine serum albumin in insulin-dependent diabetes mellitus.
    Dosch HM; Karjalainen J; VanderMeulen J
    N Engl J Med; 1994 Jun; 330(22):1616-7. PubMed ID: 8177260
    [No Abstract]   [Full Text] [Related]  

  • 60. The effect of zinc status on the immune function of diabetic rats.
    Mooradian AD; Norman DC; Morley JE
    Diabetologia; 1988 Sep; 31(9):703-7. PubMed ID: 3266157
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.